Health
A molecular trap against COVID-19 – Science Magazine
The cell surface peptidase angiotensin-converting enzyme 2 (ACE2) is the primary receptor for the spike (S) fusion protein that facilitates cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous studies are evaluating therapeutic…
The cell surface peptidase angiotensin-converting enzyme 2 (ACE2) is the primary receptor for the spike (S) fusion protein that facilitates cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous studies are evaluating therapeutic and preventive treatments that block S protein interactions with ACE2 molecules that are expressed on host cells. For example, the ACE2 binding site can be occluded by monoclonal antibodies, several of which are rapidly advancing in clinica…
-
General21 hours agoPope Leo XIV criticises nationalist politics at Sunday mass
-
Noosa News11 hours agoBike riders to cycle across the traffic lanes of the Story Bridge
-
General21 hours ago‘Miracle’ PM gets top gong in the name of the King
-
General10 hours agoHeroic surfing priest rescues father and son from rip at Cable Beach